Source: Annual Congress 2007 - Biomarkers in inflammatory lung disease
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Shimizu, K. Dobashi, H. Imai, N. Sunaga, A. Ono, K. Kaira, N. Yanagitani, T. Hisada, T. Ishizuka, M. Utsugi, H. Aoki, M. Mori (Maebashi, Gunma, Japan). CXCL12 expression in malignant mesothelioma. Eur Respir J 2007; 30: Suppl. 51, 913

Member's Comments

No comment yet.

Related content which might interest you: Expression of c-met in malignant pleural mesothelioma; an immunohistochemical study Source: Annual Congress 2007 - Inorganic dust "old timers and new kids on the block" Year: 2007 BAP1 expression and treatment outcomes in malignant mesothelioma. Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside Year: 2017 The presence of human mammaglobin transcripts in the pleural effusion is not predictive of survival in patients with malignant mesothelioma Source: Annual Congress 2008 - Biology in thoracic tumours Year: 2008 Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM) Source: Eur Respir J 2004; 24: Suppl. 48, 81s Year: 2004 The value of IL6 in differentiation between malignant and non malignant pleural effusion Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 Evaluating the role of muc4 expression in the differential diagnosis of mesothelioma and adenocarcinoma of the lung Source: Eur Respir J 2006; 28: Suppl. 50, 81s Year: 2006 ADAM10 membrane-bound protease mediates malignant pleural mesothelioma invasiveness Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018 All-trans-retinoic acid inhibits tumour growth of malignant pleural mesothelioma in mice Source: Eur Respir J 2009; 34: 1159-1167 Year: 2009 The expression of PD-1 on CD8+ T cells in malignant pleural effusion of lung cancer and its associated significance Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 Malignant pleural effusion cells show aberrant glucose metabolism gene expression Source: Eur Respir J 2011; 37: 1453-1465 Year: 2011 Effects of cisplatin and pemetrexed on 3D phenotypes of benign mesothelial and malignant pleural mesothelioma cells Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018 Forced chemokine ligand 2 overexpression renders melanoma cells capable of inducing experimental malignant pleural effusion Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008 Bevacizumab-targeted therapy for malignant pleural mesothelioma Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs Year: 2017 Alteration of neutrophil invasion toward malignant mesothelioma by Interleukin-10 Source: Eur Respir J 2002; 20: Suppl. 38, 231s Year: 2002 Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Prognostic factors in diffuse malignant pleural mesothelioma Source: Eur Respir J 2007; 30: Suppl. 51, 755s Year: 2007 Prognostic factors in diffuse malignant pleural mesothelioma Source: Eur Respir J 2003; 22: Suppl. 45, 62s Year: 2003 Diagnostic significance of ADAM8 in non-small cell lung cancer and malignant pleural effusion Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 The clinical effect and expression of alpha-methylacyl-CoA racemace (AMACR) in the differential diagnosis of malign mesothelioma and adenocarcinoma of lung Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012